Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00300391
Status:
TERMINATED
Last Update Posted:
2017-12-20
First Post:
2006-03-06
Brief Title:
ORIC-I Optimizing Recovery From Intensive Care Mechanical Ventilation and Delirium
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
ORIC-I Optimizing Recovery From Intensive Care Mechanical Ventilation and Delirium
Status:
TERMINATED
Status Verified Date:
2017-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Insufficient recruitment to meet aims
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if treating delirious intensive care unit patients with haloperidol improves mortality
Detailed Description:
Intensive care unit delirium is a serious medical condition that is associated with increased morbidity and mortality In this study 304 delirious mechanically ventilated subjects will be randomized to haloperidol 5mg IV every 12 hours or placebo to determine if treatment with haloperidol improves short and long-term mortality
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1K23HL078760-01A1 | NIH | None | httpsreporternihgovquickSearch1K23HL078760-01A1 |